Thalidomide therapy induces response in relapsed mantle cell lymphoma

Leukemia. 2003 Sep;17(9):1914-5. doi: 10.1038/sj.leu.2403058.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Drug Resistance, Neoplasm
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy*
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy
  • Salvage Therapy
  • Thalidomide / therapeutic use*
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Thalidomide